RRP12 knockdown inhibited inflammation and p53/NF-κB pathway and alleviated heterotopic ossification in mice.
- 1Department of Orthopedics, Lu'an Affiliated Hospital of Anhui Medical University, Lu'an.
Abstract
Heterotopic ossification (HO) is a pathological process, featured by the aberrant mature bone tissue in soft tissues outside the normal skeletal system, commonly occurring following trauma or major joint surgery. Ribosomal RNA Processing 12 Homolog (RRP12) has been confirmed to display multiple roles in ribosome synthesis, DNA damage, cell cycle and cell differentiation processes. However, the regulatory influences of RRP12 in HO progression keep vague and require further investigation. In this project, it was illustrated that RRP12 expression was markedly up-regulated in HO mice. Inhibition of RRP12 retarded the progression of HO in mice. Furthermore, RRP12 knockdown alleviated inflammation. Besides, it was revealed that suppression of RRP12 inactivated the p53/NF-κB pathway. Lastly, in bone marrow mesenchymal stem cells (BMSCs), it was verified that knockdown of RRP12 suppressed osteogenic differentiation of BMSCs. In conclusion, RRP12 knockdown inhibited inflammation and p53/NF-κB pathway and alleviated HO in mice. This study not only expands the current understanding of the molecular underpinnings of HO but also identifies RRP12 as a potential actionable target for therapeutic intervention. Nonetheless, further investigations are warranted to delineate the upstream regulators of RRP12 and to evaluate its translational feasibility in clinical settings.
Related
- Heterotopic mesenteric ossification after abdominal trauma
- Atraumatic iliopsoas heterotopic ossification with postoperative atypical haemolytic uraemic syndrome
- Targeting the lactate/P300/H3K18la epigenetic pathway with a mechanoadaptive biomimetic hydrogel to suppress traumatic tendon heterotopic ossification.
- Bilateral Symmetric Heterotopic Ossification of the Pubic Bones in a Former Footballer: A Case Report.
- The degeneration of uncovertebral joints on CT assessment and its association with postoperative heterotopic ossification in one- or two-level artificial cervical arthroplasty.
BibTeX
@article{hu2026rrp12,
title = {{RRP12 knockdown inhibited inflammation and p53/NF-κB pathway and alleviated heterotopic ossification in mice.}},
author = {Yuchen Hu and Zihao Zeng and Wen Jin and Chenggang Wang and Xiaofeng Liu and Yusheng Sun and Qing Gao},
journal = {European journal of histochemistry : EJH},
year = {2026},
month = oct,
doi = {10.4081/ejh.2026.4730},
url = {https://europepmc.org/article/MED/42841601},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - RRP12 knockdown inhibited inflammation and p53/NF-κB pathway and alleviated heterotopic ossification in mice.
AU - Yuchen Hu
AU - Zihao Zeng
AU - Wen Jin
AU - Chenggang Wang
AU - Xiaofeng Liu
AU - Yusheng Sun
AU - Qing Gao
PY - 2026
DA - 2026/10/07
JO - European journal of histochemistry : EJH
DO - 10.4081/ejh.2026.4730
UR - https://europepmc.org/article/MED/42841601
AB - Heterotopic ossification (HO) is a pathological process, featured by the aberrant mature bone tissue in soft tissues outside the normal skeletal system, commonly occurring following trauma or major joint surgery. Ribosomal RNA Processing 12 Homolog (RRP12) has been confirmed to display multiple roles in ribosome synthesis, DNA damage, cell cycle and cell differentiation processes. However, the regulatory influences of RRP12 in HO progression keep vague and require further investigation. In this project, it was illustrated that RRP12 expression was markedly up-regulated in HO mice. Inhibition of RRP12 retarded the progression of HO in mice. Furthermore, RRP12 knockdown alleviated inflammation. Besides, it was revealed that suppression of RRP12 inactivated the p53/NF-κB pathway. Lastly, in bone marrow mesenchymal stem cells (BMSCs), it was verified that knockdown of RRP12 suppressed osteogenic differentiation of BMSCs. In conclusion, RRP12 knockdown inhibited inflammation and p53/NF-κB pathway and alleviated HO in mice. This study not only expands the current understanding of the molecular underpinnings of HO but also identifies RRP12 as a potential actionable target for therapeutic intervention. Nonetheless, further investigations are warranted to delineate the upstream regulators of RRP12 and to evaluate its translational feasibility in clinical settings.
SN - 1121-760X
SN - 2038-8306
ER -